Anonymous ID: da3a11 Sept. 8, 2023, 1:11 p.m. No.19513142   🗄️.is 🔗kun   >>3171 >>3376 >>3423 >>3480 >>3638 >>3663 >>3797 >>3820

https://ar.iiarjournals.org/content/36/7/3771.full

Case Report: GcMAF Treatment in a Patient with Multiple Sclerosis

 

*Figure 1.

Effects of GcMAF in a patient with MS. (a): Prior to treatment (September 17, 2014). Wheelchair-bound for 4 years. (b), (c) and (d): After 6 weeks of treatment (October 31, 2014). The patient was able to stand up, walk and climb stairs with assistance for the first time. (e): After 3 months of treatment (December 12, 2014). He was undergoing walking rehabilitation and using walking sticks. (f): At the present time, he was able to peddle on an exercise bike.

Anonymous ID: da3a11 Sept. 8, 2023, 2:13 p.m. No.19513537   🗄️.is 🔗kun   >>3570 >>3663 >>3797 >>3820

>>19513409

Cancer cells destroyed by First Immune GcMAF (gcmaf.eu)

 

Cancer cells turned back into healthy cells by First Immune GcMAF gcmaf.eu

 

even without macrophages to conduct phagocytosis, the GcMAF was able to turn cancer cells back into healthy cells.

Anonymous ID: da3a11 Sept. 8, 2023, 2:27 p.m. No.19513642   🗄️.is 🔗kun

Macrophage Subtypes Polarization, Activation and Plasticity

 

M1 macrophages are antitumor, eradicate cancer, tumors, viruses and their diseases, bacteria, and other pathogens

 

M2 macrophages aid in wound repair and healing, M2's CAN assist cancer as they are pro-tumor

Anonymous ID: da3a11 Sept. 8, 2023, 2:50 p.m. No.19513788   🗄️.is 🔗kun

>>19513570

https://www.gcmafpets.com/GcMAFpets immunotherapy

GcMAFpets immunotherapy

 

Animals or vertebrates have either the same, or similar immune systems, so you can treat Fido the dog, or your horse, birds, cows, horses too.

 

A world-first range of GcMAF products that are safe & effective for any type of vertebrate animal. Aggressively boost your pet's immune response against a wide range of health issues.

Anonymous ID: da3a11 Sept. 8, 2023, 2:57 p.m. No.19513840   🗄️.is 🔗kun

Macrophages in cardiac repair: Environmental cues and therapeutic strategies

 

PDF File: https://www.nature.com/articles/s12276-019-0269-4.pdf

 

Abstract

Mammals, in contrast to urodeles and teleost fish, lose the ability to regenerate their hearts soon after birth. Central to this regenerative response are cardiac macrophages, which comprise a heterogeneous population of cells with origins from the yolk sac, fetal liver, and bone marrow. These cardiac macrophages maintain residency in the myocardium through local proliferation and partial replacement over time by circulating monocytes. The intrinsic plasticity of cardiac macrophages in the adult heart promotes dynamic phenotypic changes in response to environmental cues, which may either protect against injury or promote maladaptive remodeling. Thus, therapeutic strategies promoting myocardial repair are warranted. Adult stromal cell-derived exosomes have shown therapeutic promise by skewing macrophages toward a cardioprotective phenotype. While several key exosomal non-coding RNA have been identified, additional factors responsible for cardiomyocyte proliferation remain to be elucidated. Here I review cardiac macrophages in development and following injury, unravel environmental cues modulating macrophage activation, and assess novel approaches for targeted delivery.